Last reviewed · How we verify
HBsAg vaccine with Entecavir
HBsAg vaccine with Entecavir is a Small molecule drug developed by Genexine, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | HBsAg vaccine with Entecavir |
|---|---|
| Sponsor | Genexine, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB (PHASE1, PHASE2)
- Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients (PHASE4)
- Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HBsAg vaccine with Entecavir CI brief — competitive landscape report
- HBsAg vaccine with Entecavir updates RSS · CI watch RSS
- Genexine, Inc. portfolio CI
Frequently asked questions about HBsAg vaccine with Entecavir
What is HBsAg vaccine with Entecavir?
HBsAg vaccine with Entecavir is a Small molecule drug developed by Genexine, Inc..
Who makes HBsAg vaccine with Entecavir?
HBsAg vaccine with Entecavir is developed by Genexine, Inc. (see full Genexine, Inc. pipeline at /company/genexine-inc).
What development phase is HBsAg vaccine with Entecavir in?
HBsAg vaccine with Entecavir is in Phase 1.
Related
- Manufacturer: Genexine, Inc. — full pipeline
- Compare: HBsAg vaccine with Entecavir vs similar drugs
- Pricing: HBsAg vaccine with Entecavir cost, discount & access